CCS vs TMHC
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 11, 2026
CCS
TMHC
Investment Advisor Scores
TMHC
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CCS | TMHC | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 18.6567 | 14.5985 | TMHC |
| PEG Ratio | 0.45 | 1.4093 | CCS |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -11.8% | -26.8% | CCS |
| Earnings Growth | -64.8% | -51.2% | TMHC |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 37.8/100 | 48.8/100 | TMHC |
| Profit Margin | 2.9% | 8.8% | TMHC |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | HOLD | TMHC |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CCS
MarkdownPrice below a falling SMA50 (slope -9.0%), weak momentum, RSI 44
TMHC
MarkupPrice above SMA50, rising 50-day trend (7.0% over 20 days), RSI 75
Fundamentals Snapshot
| Metric | CCS | TMHC |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 23.4 | 11.3 |
| Trailing P/E | 15.2 | 10.7 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.1% | -0.3% |
| Gross Margin | 0.2% | 0.2% |
| Operating Margin | 0.0% | 0.1% |
| EPS | 3.75 | 6.71 |
| Dividend Yield | 0.02% | — |